Skip to main content
logo
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.8700
-0.0300 (-3.33%)
At close: Sep 1, 2026, 4:00 PM EDT
0.8500
-0.0200 (-2.30%)
After-hours: Sep 1, 2026, 7:56 PM EDT

RedHill Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.290.29--61.885.76
Revenue Growth
-96.75%----27.94%33.25%
Gross Profit
0.290.29--28.4636.35
Operating Income
-7.91-7.91-6.48-9.55-42.84-81.14
Net Income
-0.43-0.43-8.2723.92-71.67-97.74
Earnings Per Share
-0.14-0.14-6.7192.30-1162.89-2100.80
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.973.974.625.5719.9838
Total Debt
1.071.070.361.17122.6987.81
Net Cash (Debt)
2.92.94.264.4-102.71-49.81
Net Cash Growth
9.39%-31.92%-3.07%---
Net Cash Per Share
0.920.923.4616.96-1666.53-1070.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.19-7.19-8.94-16.82-29.19-65.05
Capital Expenditures
-0.01-0.01-0.01-0.01-0.2-0.12
Free Cash Flow
-7.2-7.2-8.94-16.83-29.38-65.16
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%--46.06%42.39%
Operating Margin
-2765.38%-2765.38%---69.33%-94.61%
Pretax Margin
-2825.17%-2825.17%---115.97%-113.98%
Profit Margin
-150.00%-150.00%---115.97%-113.98%
FCF Margin
-2516.08%-2516.08%---47.55%-75.98%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---1.20--
PS Ratio
17.9618.34--0.211.58